[ { "@graph" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#pubinfo" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#Head" }, { "@graph" : [ { "@id" : "http://resource.belframework.org/belframework/20131211/namespace/selventa-named-complexes/p85%2Fp110%20PI3Kinase%20Complex", "@type" : [ "http://amigo.geneontology.org/amigo/term/GO:0043234" ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_1", "@type" : [ "http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080" ], "http://purl.obolibrary.org/obo/RO_0002204" : [ { "@id" : "http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6018" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_2", "@type" : [ "http://amigo.geneontology.org/amigo/term/GO:0016301" ], "http://semanticscience.org/resource/SIO_000139" : [ { "@id" : "http://resource.belframework.org/belframework/20131211/namespace/selventa-named-complexes/p85%2Fp110%20PI3Kinase%20Complex" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_3", "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://purl.obolibrary.org/obo/BFO_0000066" : [ { "@id" : "http://purl.obolibrary.org/obo/CLO_0009251" }, { "@id" : "http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_2" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "http://www.selventa.com/vocabulary/increases" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_1" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#assertion", "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "p(HGNC:IL6) -> kin(complex(SCOMP:\"p85/p110 PI3Kinase Complex\"))" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#assertion" }, { "@graph" : [ { "@id" : "http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel", "http://purl.org/dc/elements/1.1/description" : [ { "@value" : "Approximately 61,000 statements." } ], "http://purl.org/dc/elements/1.1/rights" : [ { "@value" : "Copyright (c) 2011-2012, Selventa. All rights reserved." } ], "http://purl.org/dc/elements/1.1/title" : [ { "@value" : "BEL Framework Large Corpus Document" } ], "http://purl.org/pav/authoredBy" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_5" } ], "http://purl.org/pav/version" : [ { "@value" : "20131211" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_4", "http://www.w3.org/ns/prov#value" : [ { "@value" : "IL-6 treatment led to activation of the mitogen-activated protein kinase (MAPK) and the phosphatidylinositol 3'-kinase (PI3K) pathways. Inhibition of MAPK or PI3K activity reversed IL-6- and oncostatin M-stimulated migration. For transient transfections, plasmids were introduced into the cells using Superfect transfection reagent (Qiagen). A HA-tagged MAPK (Erk2) construct (kindly provided by M. El-Shemerly and Y. Nagamine; Friedrich Miescher Institute, Basel, Switzerland) was cotransfected with a DN EGF receptor construct lacking 533 COOH-terminal amino acids MAPK kinase inhibitors PD98059 (20 uM; New England Biolabs) or UO126 (50 uM; Promega, Madison, WI PD98059, which is known to specifically inhibit the ERK-activating kinase MEK1, has been widely used to assess the effects of dampening ERK activation. MEK inhibitor UO126 (Promega, MEK Inhibitor U0126 is a chemically synthesized organic compound that inhibits activation of MAPK (ERK 1/2) by inhibiting the kinase activity of MAP Kinase Kinase (MAPKK or MEK 1/2)." } ], "http://www.w3.org/ns/prov#wasQuotedFrom" : [ { "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/11196191" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_5", "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Selventa" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#assertion", "http://www.w3.org/ns/prov#hadPrimarySource" : [ { "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/11196191" } ], "http://www.w3.org/ns/prov#wasDerivedFrom" : [ { "@id" : "http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel" }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#_4" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#provenance" }, { "@graph" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU", "http://purl.org/dc/terms/created" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2014-07-03T14:31:39.817+02:00" } ], "http://purl.org/pav/createdBy" : [ { "@id" : "http://orcid.org/0000-0001-6818-334X" }, { "@id" : "http://orcid.org/0000-0002-1267-0234" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RAchhUlX8-bXqvxGre5FBYNMhxHFh0QE12TJtQsC-loOU#pubinfo" } ]